Published in Drug Law Weekly, May 6th, 2008
The South Korea Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on South Korea's pharmaceuticals and healthcare industry.
In BMI's new Business Environment Rankings for Q208, South Korea ranks third out of 14 markets assessed, below Japan and Australia, which rose to pole position from third in the previous period. Despite slipping one place, South Korea remains one of the most attractive regional markets. Key drivers of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.